View topic-related background literature as well as publications of the QSPainRelief consortium itself. Once new publications are available, we list them here. Open access listings are linked directly to the full-text version. All others lead to the respective journal repository or publisher. Consortium members, please fill out the manuscript synopsis template when planning a new publication and send it to the PMO. For QSPainRelief press releases please go to DOWNLOADS. To receive our project newsletter, please subscribe here!
QSPainRelief publications (total count: 25)
2025
- Bakker WA et al. (2025). Application of a Nociceptive Test Battery to Assess Potential Synergy between Two Analgesics in Healthy Subjects. ACS Pharmacol Transl Sci, 8(3): pp. 819–830. PDF
- Budda D et al. (2025). Beta-endorphin is the key endogenous opioid influencing morphine µ-opioid receptor occupancy in rat hypothalamus: a binding kinetic model analysis. Eur J Pharm Sci, 212: 107195. PDF
- Gousset S et al. (2025). Novel approaches to investigate central sensitisation: from experimental models to clinical perspectives. PhD Thesis, Université catholique de Louvain, Louvain-la-Neuve, Belgium: pp. 1 -233. PDF
- Gousset S et al. (2025). Preoperative susceptibility to developing secondary hyperalgesia is associated with post-thoracotomy pain at 2 months. 29: e4768. PDF
- Gülave B et al. (2025). Do P-glycoprotein-mediated drug-drug interactions at the blood-brain barrier impact morphine brain distribution? J Pharmacokinet Pharmacodyn, 52, 11. PDF
- Gülave et al. (2025). Prediction of the Extent of Blood–Brain Barrier Transport Using Machine Learning and Integration into the LeiCNS-PK3.0 Model. Pharm Res, 42, 281–289. PDF
- Ortiz et al. (2025). A mathematical formalism to quantify drug-target residence time. Biochem Pharmacol, 239: 117037. PDF
- Rinaudo CM et al. (2025). Navigating the biopsychosocial landscape: A systematic review on the association between social support and chronic pain. 20(4): e0321750. PDF
- van Valkengoed et al. (2025). Reliability of in vitro data for the mechanistic prediction of brain extracellular fluid pharmacokinetics of P-glycoprotein substrates in vivo; are we scaling correctly? J Pharmacokinet Pharmacodyn, 52: 16. PDF
2024
- Bertayli M et al. (2024). PK-PD model of morphine, pregabalin and their combination to assess the opioid-sparing effect. Population Approach Group Europe 2024 (PAGE Conference 32): Drug/Disease Modelling – CNS: Poster Abstract No. 11143. PDF
- Budda D et al. (2024). Non-linear blood-brain barrier transport and dosing strategies influence receptor occupancy ratios of morphine and its metabolites in pain matrix. Br J Pharmacol, 181 (20): pp. 3856-3868. PDF
- Ortiz AJ et al. (2024). Time-dependent ligand-receptor binding kinetics and functionality in a heterodimeric receptor model. Biochem Pharmacol, 225: 116299. PDF
2023
- Del Mar Cajiao-Manrique M, Maldonado R, and Martín-García E (2023). A male mouse model of WIN 55,212–2 self-administration to study cannabinoid addiction. Front Pharmacol, 14: 1143365. PDF
- Del Mar Cajiao-Manrique M et al. (2023). THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model. Front Psychol, 14: 1148993. PDF
- Díaz O et al. (2023). Allosteric binding cooperativity in a kinetic context. Drug Discov Today, 28 (2): 103441. PDF
- García-Blanco A et al. (2023). Role of CB2 cannabinoid receptor in the development of food addiction in male mice. Neurobiol Dis, 179: 106034. PDF
- Gülave B et al. (2023). Does nonlinear blood-brain barrier transport matter for (lower) morphine dosing strategies? Eur J Pharm Sci, 187: 106482. PDF
- Saleh MAA et al. (2023). Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice. Pharm Res, 40: pp. 2555–2566. PDF
2022
- Cabañero D et al. (2022). Operant Self-medication for Assessment of Spontaneous Pain Relief and Drug Abuse Liability in Mouse Models of Chronic Pain. Bio Protoc, 12(5): e4348. PDF
- Díaz O, Renault P, and Giraldo J (2022). Evaluating Allosteric Perturbations in Cannabinoid Receptor 1 by In Silico Single-Point Mutation. ACS OMEGA, 7(42): pp. 37873–37884. PDF
- García-Blanco A et al. (2022). miRNA signatures associated with vulnerability to food addiction in mice and humans. J Clin Invest, 132(10): e156281. PDF
- Mayneris-Perxachs J et al. (2022). Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function. ISME J, 16(9): pp. 2181–2197. PDF
2021
- Renault P and Giraldo J (2021). Dynamical Correlations Reveal Allosteric Sites in G-Protein-Coupled Receptors. Int J Mol Sci, 22: 187. PDF
- Ricarte A, Dalton JAR, and Giraldo J (2021). Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns. J Chem Inf Model, 61 (3): 1251–1274. PDF
2020
- Bruzzese A, Dalton JAR, and Giraldo J (2020). Statistics for the analysis of molecular dynamics simulations: providing P values for agonist-dependent GPCR activation. Sci Rep, 10: 19942. PDF
Background reading
- Kirouac DC et al. (2019). Reproducibility of Quantitative Systems Pharmacology Models: Current Challenges and Future Opportunities. CPT Pharmacometrics Syst Pharmacol, 8 (4): 205-210
- Scholz J et al. (2019). The IASP Classification of Chronic Pain for ICD-11: Chronic Neuropathic Pain. Pain, 160 (1): pp. 53-59
- Mills SEE et al. (2019). Chronic Pain: A Review of Its Epidemiology and Associated Factors in Population-Based Studies. Br J Anaesth, 123 (2): pp. e273-e283
- O’Brien T et al. (2017). European Pain Federation Position Paper on Appropriate Opioid Use in Chronic Pain Management. Eur J Pain, 21 (1): pp. 3-19
- Glare P et al. (2019). Transition from acute to chronic pain after surgery. Lancet, 393 (10180): pp. 1537-1546